Skip to main content

1 Result(s)

within Caleb Bliss Remove this filter Neurosciences Remove this filter Psychiatry Remove this filter Psychopharmacology Remove this filter

and

  1. Article

    Open Access

    Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

    SPD489-404 was the first 2-year safety study of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. In accordance with advice from the European...

    David R. Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson… in CNS Drugs (2018)

    Download PDF (768 KB) View Article